Baird has initiated its coverage of newly IPO’d medical device maker Beta Bionics (NASDAQ:BBNX) with a Neutral recommendation ...

Fintel reports that on February 20, 2025, Baird upgraded their outlook for Amplitude (NasdaqCM:AMPL) from Neutral to ...

Burlington woman’s sense of mission, devotion to civic engagement and unstoppable drive to help the oppressed left indelible ...

Baird upgraded Amplitude (AMPL) to Outperform from Neutral with a price target of $17, up from $12. The company reported solid Q4 results, ...

I fell in love with tax, trusts and estates in law school. I was fortunate to begin my career as a wealth planner at a local ...

As an attorney, she dedicated her life to representing those who had no voice, particularly women in domestic situations — especially those who had been abused, poor and forgotten. Her ...

Baird raised the firm’s price target on Watsco (WSO) to $560 from $540 and keeps an Outperform rating on the shares. The firm updated its model ...

Business address: 751 W. 4th St., Suite 320, Winston-Salem ...

Former legislator and lawyer Sandy Baird was a champion of the underprivileged, including women, low-income Vermonters and ...

Sandy Baird, an attorney and former Vermont lawmaker, is being remembered for her work on a wide range of issues, from ...

Citing the difficulty of predicting interest-rate changes consistently, Baird’s approach begins with matching this fund’s overall interest-rate sensitivity, or duration, to the Bloomberg US ...

Fluor (NYSE:FLR – Get Free Report) had its price target cut by investment analysts at Robert W. Baird from $58.00 to $46.00 ...